Harbour BioMed docks with BMS in antibody discovery, development deal worth up to $1.1B
Harbour BioMed docks with BMS in antibody discovery, development deal worth up to $1.1B
Body unavailable. Use the original source.
Harbour BioMed docks with BMS in antibody discovery, development deal worth up to $1.1B
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.